CSafe Announced Biopharmaceutical Cold Chain Sales Director for the United Kingdom & Ireland

CSafe Global furthers the expansion of their diverse sales team with the addition of John Bullon as Director of Sales for the UK and Ireland.
Mr. Bullon will be responsible for supporting CSafe’s overall business progression, while he maintains and develops customer relationships, penetrates target markets and promotes revenue objectives. With a proven track record and over a decade of experience as an international senior sales manager, John will be an essential global market contributor to the company.
John joins CSafe having held roles within medical diagnostic contract sales and possesses a strong background with medical devices, immunoassays and personalized medicine. He is an accomplished professional who understands the importance of thinking outside the box to satisfy customer needs. “I am privileged to join such a driven, ambitious, and customer-focused organization. From the professionalism of the personnel in every department to the extensive range of products and services, the quality of the CSafe way is evident. I am looking forward to increasing CSafe Global’s footprint within the UK & Ireland”, commented John.
Remarking on the expansion, Nadine Siqueland, Vice President of Global Sales stated: “John’s background in Medical Device International Sales provides him with the skills, knowledge and tools to operate within our highly complex global business environment. We welcome the expertise he brings to the robust Ireland and UK biopharma markets”.
CSafe Global has become a world leader in temperature-controlled solutions, consistently meeting the challenges of complex cold chains while focusing on serving patients who require life-saving and life enhancing biopharmaceutical products.

CSafe Global Appoints Valerie Vincent as Director of Strategic Sales for the Western USA

In a growing move to support their evolving biopharmaceutical customers in the United States, CSafe has announced that Valerie Vincent has joined them as the western USA Director of Strategic Sales.
Valerie Vincent will be responsible for promoting CSafe’s range of products while maintaining and communicating market knowledge, building long-term customer relationships, and developing structured sales plans. With an extensive background as a global senior sales executive with outstanding leadership in generating business growth in cutting edge technologies in Life Sciences and IT, Valerie will serve as a vital advocate for CSafe’s industry growth design.
Valerie joins the CSafe Global company after years of managing sales teams and selling innovative and highly complex technologies into new and existing markets such as her previous positions with Sanofi, ThermoFisher, Roche Diagnostics, Stanford University and Inscopix. Valerie Vincent has achieved her MBA from Columbia University, a PhD in Neurosciences and an MSc in Biomedical Sciences. “Having worked in R&D, GLP and GMP environments in large pharmaceutical companies, I really understand the incredible complexity, cost and time it takes to reach the final products”, noted Valerie. “Being able to provide the best and safest solutions for bringing these temperature-sensitive goods to patients around the globe is critical, and I am very excited to be part of this outstanding team that is solutions-driven and always has the end user in mind.”
CSafe maintains a position within the pharmaceutical cold chain industry that exceeds the standards and drives the advancement of world-class temperature-controlled solutions. Valerie’s expertise and wide range of skills will allow her to integrate into the CSafe network successfully and provide valuable global business development insight.
Commenting on the new appointment, Nadine Siqueland, Vice President of Global Sales said: “Valerie has a proven record of building long term business relationships within the global biopharmaceutical market. She brings a rare combination of advanced science and selling skills with a strong connection to the start-up, medium and large Life Science companies that dominate in the West. As CSafe Global increasingly becomes the cold chain partner of choice, protecting the most critical lifesaving and life enhancing medicines, Valerie will be a key contributor in our ever expanding global sales team.”
About CSafe Global
CSafe Global manufactures AcuTemp® brand passive packaging and hand-held mobile carriers, the CSafe® brand of active containers, and is the exclusive manufacturer and provider of ThermoCor® vacuum insulation. The active solution product assortment includes the industry leading CSafe RKN, which utilizes heating and compressor-driven cooling technology to eliminate the risks associated with extreme ambient conditions as well as the conditioning, cost, aggravation and environmental challenges associated with dry ice and PCM’s. CSafe Global’s AcuTemp brand has provided temperature management solutions since its founding more than 25 years ago. The courier is a simple-to-use, reusable temperature management system with multiple sizes, temperature ranges and durations designed to protect vital shipments during last mile delivery. The passive packaging assortment includes solutions for 2-8°C, CRT and frozen shipments with temperature hold times up to 240 hours.

Pharma Focus: CSafe Hosts Successful Korean BioPharma Workshop

CSafe, the world’s largest provider of active and passive cold chain solutions, hosted a highly-successful workshop for over 120 delegates from the leading Korean biopharmaceutical manufacturing and logistics service sector.
Under the title ‘Pharma Focus: Introducing Biosimilars Successfully’ the event was held in Incheon and attracted an audience comprised of many key stakeholders involved in the supply chain for this fast growing South Korean industry segment which by 2019, is expected to almost double in value to 150 billion Won ($130m).
Brian Kohr, President and CEO of CSafe Global, welcomed delegates and spoke of how CSafe Global is continuing to grow to support the Korean biopharmaceutical cold chain including an enhanced local service facility and the extension of its product availability in the region.
Speakers from top forwarding companies outlined through case studies how their partnership with CSafe continues to allow South Korean manufacturers effective incident-free door-to-door delivery of biopharmaceutical products from Korea. Exelsius also gave delegates an update on the important aspect of GDP regulations and their global application, particularly in relation to qualification of supply chain partners.
A well-respected and highly experienced member from a successful biopharmaceutical company and a leading manufacturer in this sector, delivered an insightful address on best practices in supply chain qualification that drew considerable interest from the audience during the subsequent sixty-minute Q & A which covered a wide variety of topics from packaging techniques through to data collection and air cargo labeling regulations.
Kevin Lee, CSafe Director of Sales Korea said, “We are naturally delighted to have been able to host this event to such an extensive and interested audience and provide them with information that will enhance their knowledge and understanding of the international supply chain for biopharmaceuticals.”
About CSafe Global
CSafe Global manufactures AcuTemp® brand passive packaging and hand-held mobile carriers, the CSafe® brand of active containers, and is the exclusive manufacturer and provider of ThermoCor® vacuum insulation. The active solution product assortment includes the industry leading CSafe RKN, which utilizes heating and compressor-driven cooling technology to eliminate the risks associated with extreme ambient conditions as well as the conditioning, cost, aggravation and environmental challenges associated with dry ice and PCM’s. CSafe Global’s AcuTemp brand has provided temperature management solutions since its founding more than 25 years ago. The courier is a simple-to-use, reusable temperature management system with multiple sizes, temperature ranges and durations designed to protect vital shipments during last mile delivery. The passive packaging assortment includes solutions for 2-8°C, CRT and frozen shipments with temperature hold times up to 240 hours.